Analysis of the 2023 data shows that South Africa has the highest mortality rate from cervix uteri malignant neoplasms at 14.6 per hundred thousand women, followed by Lithuania (12.2) and Latvia (11.7). The lowest rates are seen in Finland (1.6) and Switzerland (1.5). Year-on-year variations reveal significant decreases in Iceland (-11.5%) and Finland (-4.36%), while Luxembourg saw a notable increase (19.67%). Other countries like Bulgaria and Estonia showed moderate increases, while Slovakia and Denmark experienced declines. Over the last five years, variations reveal a downward trend in most developed countries.
Future trends to watch include the impact of enhanced screening programs, HPV vaccination rollouts, and healthcare accessibility improvements in countries with higher mortality rates. Continued research into better detection and treatment methods will likely contribute to decreasing global trends in cervix uteri malignant neoplasms mortality.
Top countries in Cervix Uteri Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Female Deaths) Per Hundred Thousand Women | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 South Africa | 14.6 | 2023 | +1.39% | +1.58% | View data |
| 2 | 2 Lithuania | 12.2 | 2023 | 0% | -0.64% | View data |
| 3 | 3 Latvia | 11.7 | 2023 | +2.63% | 0% | View data |
| 4 | 4 Bulgaria | 9.4 | 2023 | 0% | +2.28% | View data |
| 5 | 5 Estonia | 8.6 | 2023 | 0% | +2.24% | View data |
| 6 | 6 Poland | 7.8 | 2023 | 0% | -0.75% | View data |
| 7 | 7 Slovakia | 7.8 | 2023 | 0% | -1.7% | View data |
| 8 | 8 Peru | 7.6 | 2023 | +1.33% | +1.37% | View data |
| 9 | 9 Hungary | 7.4 | 2023 | -1.33% | -1.55% | View data |
| 10 | 10 Colombia | 7 | 2023 | 0% | +0.58% | View data |
